Identification Novel Drug Target for AD: Combined Mendelian Randomization Analysis and Bioinformation Analysis
T Lu, Y Li, R Huang, X Liu - Available at SSRN 4826172 - papers.ssrn.com
Background: While AD research has advanced significantly, there hasn't been a major
advancement in AD therapy, in part because there aren't enough suitable therapeutic …
advancement in AD therapy, in part because there aren't enough suitable therapeutic …